Kim D. Blickenstaff - May 23, 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
/s/ Rachel Malina, Attorney-in-Fact for Kim D. Blickenstaff
Stock symbol
TNDM
Transactions as of
May 23, 2024
Transactions value $
$229,371
Form type
4
Date filed
5/24/2024, 07:21 PM
Previous filing
May 26, 2023
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $229K +4.43K +33.06% $51.73 17.8K May 24, 2024 Direct
holding TNDM Common Stock 205K May 23, 2024 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -4.43K -100% $0.00* 0 May 24, 2024 Common Stock 4.43K Direct F2, F3, F4
transaction TNDM Restricted Stock Unit Award $0 +4.39K $0.00 4.39K May 23, 2024 Common Stock 4.39K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
F2 Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F3 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F4 RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
F5 Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).